Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$576,824
+$19,086 QoQ
Shares Held
3,042
+7.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#811
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. AZN ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
3,042 | $576,824 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $576,824 | 3,042 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $557,738 | 2,828 | Shares | Sole | 2026-06-01 | |
| No filing history on record for this holder in this stock. | ||||||